| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/20/2002 | US20020077256 Novel detergent compositions with enhanced depositing, conditioning and softness capabilities |
| 06/20/2002 | US20020076813 Stabilizing diluent for polypeptides and antigens |
| 06/20/2002 | US20020076810 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders |
| 06/20/2002 | US20020076449 Preserved cyclodextrin-containing compositions |
| 06/20/2002 | US20020076447 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticle, and therapeutic agent for treating zinc deficiency |
| 06/20/2002 | US20020076445 Eukaryotic cells and method for preserving cells |
| 06/20/2002 | US20020076444 Novel method for obtaining microspheres and resulting products |
| 06/20/2002 | US20020076443 Multiple phase cross-linked compositions and uses thereof |
| 06/20/2002 | US20020076441 A biodegradable gel matrix and a microparticle system wherein the microparticle is embedded in the biodegradable gel matrix, from which bioactive agent is released in a controlled manner |
| 06/20/2002 | US20020076439 Orally administerable drug in combination with an effervescent as a penetration enhancer for influencing absorption of a drug in the gastrointestinal tract |
| 06/20/2002 | US20020076432 Encapsulated long chain alcohols |
| 06/20/2002 | US20020076426 Use of terpene alcohol ethoxylates as solubilizers in cosmetic or pharmaceutical preparations or concentrates for food preparations |
| 06/20/2002 | US20020076421 Oral liquid mucoadhesive compositions |
| 06/20/2002 | US20020076406 Multivalent target binding protein |
| 06/20/2002 | US20020076399 Treatment of immune diseases |
| 06/20/2002 | DE10145910A1 Ophtalmologische Formulierung mit verlangsamter Freisetzung und langer Verweildauer sowie Herstellungsverfahren hierfür Ophthalmic formulation with delayed release and long residence time and manufacturing method thereof |
| 06/20/2002 | DE10062712A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden New pharmaceutical compositions based on anticholinergics and corticosteroids |
| 06/20/2002 | DE10061525A1 New tetradecapeptides, containing alpha-aminoisobutyric acid residues and a terminal leucinol residue, useful for forming central nervous system-penetrating lipophilic conjugates of drugs, e.g. antibiotics |
| 06/20/2002 | DE10059318A1 Kosmetische Mittel enthaltend Alk(en)ylbernsteinsäurederivate Cosmetic products containing ylbernsteinsäurederivate alk (en) |
| 06/20/2002 | DE10050246C1 Calciumdoppelsalze, Verfahren zu ihrer Herstellung und ihre Verwendung zur Konservierung Calcium double salts, processes for their preparation and their use for preserving |
| 06/20/2002 | CA2447900A1 Drug delivery compositions and medical devices containing block copolymer |
| 06/20/2002 | CA2445091A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | CA2436830A1 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | CA2434915A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | CA2431896A1 Compound |
| 06/20/2002 | CA2431858A1 Targeted enzymes comprising substrate recognition sites and target binding sites |
| 06/20/2002 | CA2431852A1 Herbal pharmaceutical compositions for treating immunological disorders |
| 06/20/2002 | CA2431716A1 Targeted enzyme prodrug therapy |
| 06/20/2002 | CA2431285A1 Microparticles with an improved release profile and method for the production thereof |
| 06/20/2002 | CA2431250A1 Composition for regulating animal growth, method of manufacture and use thereof |
| 06/20/2002 | CA2431172A1 Nmda receptor antagonist pharmaceutical compositions |
| 06/20/2002 | CA2431044A1 Oral compositions and use thereof |
| 06/20/2002 | CA2427625A1 Preparation of drug particles using evaporation precipitation into aqueous solutions |
| 06/19/2002 | EP1215257A2 Warming composition |
| 06/19/2002 | EP1214945A2 Method and medicament for inhibiting the expression of a defined gene |
| 06/19/2002 | EP1214944A1 Percutaneous absorption agents |
| 06/19/2002 | EP1214940A1 Methods of enhancing the therapeutic activity of NSAIDs and compositions of zwitterionic phospholipids useful therein |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214894A1 Food formulations with a high calcium content |
| 06/19/2002 | EP1214886A1 Acidic oil-in-water type emulsion composition |
| 06/19/2002 | EP1214400A2 Zymogen activation system |
| 06/19/2002 | EP1214361A1 Temperature sensitive polymers |
| 06/19/2002 | EP1214340A2 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/19/2002 | EP1214326A1 Inhibitors of prenyl-protein transferase |
| 06/19/2002 | EP1214300A2 Rate-controlled particles |
| 06/19/2002 | EP1214101A1 Method for detecting and killing epithelial cancer cells |
| 06/19/2002 | EP1214099A1 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries |
| 06/19/2002 | EP1214097A1 Nucleic acids encoding polyepitope polypeptides |
| 06/19/2002 | EP1214096A2 Taxane prodrugs |
| 06/19/2002 | EP1214095A1 Use of anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 06/19/2002 | EP1214094A1 Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 06/19/2002 | EP1214093A1 Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 06/19/2002 | EP1214078A1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 06/19/2002 | EP1214077A2 Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury |
| 06/19/2002 | EP1214069A1 High affinity dna binding compounds as adjuvants in antisense technology |
| 06/19/2002 | EP1214067A1 Methods for treating cell proliferative disorders including cancer |
| 06/19/2002 | EP1214066A1 Formation of nanometer-scale structures |
| 06/19/2002 | EP1214064A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 06/19/2002 | EP1214059A2 Surface modified particulate compositions of biologically active substances |
| 06/19/2002 | EP1214058A1 Method to obtain microparticles |
| 06/19/2002 | EP1214056A1 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 06/19/2002 | EP1214055A2 Pharmaceutical gel containing active substances |
| 06/19/2002 | EP1214054A1 Intranasal influenza virus vaccine |
| 06/19/2002 | EP1214053A1 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 06/19/2002 | EP1214052A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 06/19/2002 | EP1214043A2 Cosmetic and/or pharmaceutical preparations |
| 06/19/2002 | EP1213974A1 Directly compressable raw material for tablets |
| 06/19/2002 | EP1213972A1 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of "fast sugars" |
| 06/19/2002 | EP1213964A1 Phytochemicals for treatment of mastalgia and endometriosis |
| 06/19/2002 | EP1014943B1 Medical aerosol formulations |
| 06/19/2002 | EP0946198B1 Method of stabilizing troponin I (cTnI) via conjugation with an active polymer |
| 06/19/2002 | EP0906101B1 Slow-release pharmaceutical formulations containing mizolastin |
| 06/19/2002 | EP0879062B1 Nucleic acid delivery vehicle |
| 06/19/2002 | EP0878201B1 Medicaments for the treatment or prevention of thrombocytopenia |
| 06/19/2002 | EP0869817B1 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
| 06/19/2002 | EP0861084B1 Improved process and composition for therapeutic cisplatin (cddp) |
| 06/19/2002 | EP0852497B1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 06/19/2002 | EP0730474B1 Estramustine formulations with improved pharmaceutical properties |
| 06/19/2002 | EP0462215B1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 06/19/2002 | CN1354754A Injectable anthelmintic formulation |
| 06/19/2002 | CN1354678A Polyethyleneimine: DNA formulations for aerosol delivery |
| 06/19/2002 | CN1354677A Topical compositions for prostaglandin E1 delivery |
| 06/19/2002 | CN1354672A Composition comprising alkaline sphingomyelinase for use as dietetic preparation, food supplement or pharmaceutical product |
| 06/19/2002 | CN1354669A Pharmaceutical compositions of erythropoietin |
| 06/19/2002 | CN1354667A Use of camptotheicin derivatives with reduced gastrointestinal toxicity |
| 06/19/2002 | CN1354665A Sustained release ranolazine formulations |
| 06/19/2002 | CN1354664A Injectable naltrexone microsphere compositions and their use in reducing consumption of heroinb and alcohol |
| 06/19/2002 | CN1354656A Compositions and methods for mucosal delivery |
| 06/19/2002 | CN1354655A Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 06/19/2002 | CN1354654A Transdermal therapeutic system with neutralized pressure sensitiivty acrylic adhesive patch |
| 06/19/2002 | CN1354653A Compressed compositions comprising clarified xanthan gum |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354622A Prostaglandin compound, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
| 06/19/2002 | CN1353990A Preparation for analgesia and anesthesia or curing drug dependence |
| 06/19/2002 | CN1086396C Preparation of water-soluble copolymers of N-vinyllactam and hydrophobic comonomer |
| 06/18/2002 | US6408051 Electromagnetic object detector provided with an additional electrode and intended for a medical radiation apparatus |
| 06/18/2002 | US6407278 Stable amorphous amifostine compositions and methods for the preparation and use of the same |
| 06/18/2002 | US6407218 Monoclonal antibodies, antigen specific for immunology |
| 06/18/2002 | US6407178 Complexing |
| 06/18/2002 | US6407158 Neutralized pyrrolidone polymer containing itaconic acid and diamine monomers; cosmetics, shampoo |